Search results for: vitamin D

FDA Issues Safety Alerts for Bisphosphonates & SGLT2 Inhibitors

Michele B. Kaufman, PharmD, BCGP | May 20, 2015

Safety The Food and Drug Administration (FDA) has updated the Warnings and Precautions sections of prescribing information for the bisphosphonate agents, including risedronate sodium tablets and combinations with calcium (Actonel/Atelvia), alendronate and combinations with vitamin D (Binosto/Fosamax), ibandronate (Boniva), etidronate (Didronel) and the RANK-ligand inhibitor denosumab (Prolia/Xgeva).1 This information relates to an increased risk for…

2014 ACR/ARHP Annual Meeting: Bone Fracture Concerns in Children

Susan Bernstein | April 1, 2015

Recognizing, reducing risk of bone fractures in pediatric patients with rheumatic disease, taking glucocorticoid therapy

2014 ACR/ARHP Annual Meeting: Rheumatologic Research Uncovers Clues to Therapies

Susan Bernstein | April 1, 2015

Studies explore role of STING pathway in bone remodeling, denosumab to reduce fracture risk, autotaxin’s role in fibrosis, SSc

2014 ACR/ARHP Annual Meeting: Lupus Nephritis

Mary Beth Nierengarten | February 1, 2015

Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication

2014 ACR/ARHP Annual Meeting: Wellness Ultimate Goal in Rheumatology Patient Care

Susan Bernstein | January 1, 2015

Physician Leroy Hood, MD, PhD, shares his vision of genomics-driven, proactive, wellness-focused medicine in keynote address

Nurses’ Health Study Continues to Offer Valuable Patient Data

Susan Bernstein | January 1, 2015

Nurses’ cohort of 38 years provides wealth of patient information, research for rheumatologists

Atypical Fractures Associated with Bisphosphonates

Michele B. Kaufman, PharmD, BCGP | November 1, 2014

Plus, FX006, odanacatib and other rheumatology drug news, safety updates

Persistent Symptomatic Hypocalcemia Due to Denosumab: A Case Review

Lyudmila Kirillova, MD, & William Ayoub, MD | October 1, 2014

Patients with osteoporosis and impaired renal function are at risk

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | July 1, 2014

An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid

Lessons Learned from a Patient with Rheumatoid Arthritis

Sarah Troxell, RN, BSN | June 1, 2014

Sarah Troxell, RN, BSN, imparts what she’s learned about RA and medication management, assembling a team of health professionals and battling other health issues